Oral estradiol
Oral tablet
- Charge
- $79.00 per month on a 12-month plan
- First payment
- $79.00 at the first monthly charge
- Monthly
- ≈ $79.00/mo derived
- Membership
- $0/mo
- Supply
- 30-day supply
- Commitment
- 12-month plan · rate tied to the term
Program record · Telehealth · oral estradiol and estradiol patch
Hers publishes $79 a month for oral estradiol and $134 a month for the estradiol patch with progesterone, both on a 12-month plan. Provider access and messaging are inside the charge, and no separate consultation or membership fee is listed.
2 offers · Source read Oct 23, 2026
Read from the provider's own pricing page · standard rate, no promotional pricing.
One row per offer. The charge stays as billed, and the monthly equivalent is derived and labeled as derived.
Oral estradiol
Oral tablet
Estradiol patch with progesterone
Transdermal patch plus oral capsule
How the billing works
One monthly charge covers the medication, provider access and messaging. The plan can be paused or canceled from the account, per the provider's own terms.
Where the record stops
The published monthly rate is tied to a 12-month plan. The record uses that rate because it is the only one Hers publishes, and it says which plan the figure belongs to rather than presenting it as an unconditional price.
Sourcing
Published in full rather than collapsed. A record is only as citable as the rows behind it, including the rows that establish nothing.
7 source rows · every row dated
Monthly plan charge
ReportedOral estradiol $79 a month; estradiol patch with progesterone $134 a month. Both are stated against a 12-month plan.
forhers.com/menopauseRead Oct 23, 2026
What the charge includes
ReportedMedication, unlimited provider access and messaging are described as included. No separate consultation or membership fee is listed.
forhers.com/menopauseRead Oct 23, 2026
Month-to-month rate
Not establishedThe provider states a shorter term costs more without publishing the amount, so no figure is recorded.
Provider pricing pageRead Oct 23, 2026
Progesterone in the oral plan
ReportedThe $79 oral path names oral estradiol together with oral micronized progesterone where a uterus is present. The tier is not itemised line by line, so the $79 offer is carried against estradiol and the combined patch plan is recorded separately at $134.
forhers.com/menopauseRead Oct 23, 2026
Monthly plan charge
Reported$134 a month for the estradiol patch with progesterone on a 12-month plan.
forhers.com/menopauseRead Oct 23, 2026
What the charge includes
ReportedBoth medicines, provider access and messaging, with no separate consultation fee.
Provider pricing pageRead Oct 23, 2026
Billing term
ReportedThe rate is stated against a 12-month plan. Cancellation and pausing are available from the account.
Provider pricing pageRead Oct 23, 2026
A field with no published answer reads not established. It is never shown as a dash, because a dash is where a zero usually hides.
Billed with Oral estradiol and Oral micronized progesterone inside one offer.
Billed with Estradiol patch and Progesterone inside one offer.
State availability varies by product. No coverage list is published.
Commitment, cancellation and refund wording above is quoted as Hers published it on Oct 23, 2026. It is not a statement of a legal entitlement: auto-renewal and cancellation rules differ by state, and the provider can change its terms after that date.
Nothing here is medical advice. Whether a treatment is appropriate is a decision for a licensed clinician. These terms describe a payment, not whether a treatment is appropriate for anyone.
How this is funded
No program pays for a position here, and no outbound link carries a referral commission. That is a flag in the data rather than a sentence in the copy: if either ever changes, every page that shows this notice discloses it automatically.
Score
The published total is out of 100, but 75 of those points are the same for every listed record. They are the inclusion baseline, not something this program earned. The informative figure is the detail points on top of that baseline, out of 25, earned across five published components: price level, price completeness, required fees priced, terms on record, and whether dose and coverage are stated. It measures how completely the charges are published, not clinical quality, effectiveness, safety or medical endorsement, and no editorial mark is applied.
Disclosure detail earned
20.9of 25
75 of the 95.9 is the fixed inclusion baseline shared by every listed record. The remaining 20.9 is what this record earned on the five components below.
The five components that earn those 25 points
The lowest all-in monthly equivalent the record can derive. Full marks at or below $75, none at or above $400, linear between. No marks at all where the all-in figure is withheld.
The share of a program's offers that carry a derivable all-in monthly figure. The heaviest single weight, because a published all-in price for every offer sold is the thing this index measures.
The share of a program's offers where no required consultation, lab, membership or startup fee is left without an amount.
Two for stating that there is no minimum term, one for stated cancellation terms, one for a membership stated as a number. A stated lock-in earns nothing here.
One for stating whether the charge varies by dose, one for recording where the program ships.
This score measures pricing disclosure completeness. It is not a measure of clinical quality, effectiveness or safety, and it is not a medical endorsement of any program.
Labs included
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Follow-ups included
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
No separate membership
No membership is billed on top of the medication charge, or a stated membership is already inside it.
Checked Oct 23, 2026
Flat across dose
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Month to month
The sources read establish the opposite of this statement at the check date.
Checked Oct 23, 2026
Compounded available
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
FDA-approved only
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Ships to all 50 states
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Each line records what the sources established on the check date. A verified line is a finding, a verified-not-met line is the opposite finding, and a not-verified line means the source did not say. A criterion is not a ranking and not a mark of quality.
Last modified Oct 23, 2026